- Easy Tracking In The Watchlist
Big movements in Pasithea Therapeutics Corp. stock price on Monday moving 13.13% between high and low
(Updated on Jun 29, 2026)
The Pasithea Therapeutics Corp. stock price fell by -3.18% on the last day (Monday, 29th Jun 2026) from $0.543 to $0.526. During the last trading day the stock fluctuated 13.13% from a day low at $0.513 to a day high of $0.580. The price has fallen in 7 of the last 10 days and is down by -11% for this period. Volume has increased on the last day by 174 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 406 thousand shares were bought and sold for approximately $213.76 thousand.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -25.21% during the next 3 months and, with a 90% probability hold a price between $0.357 and $0.529 at the end of this 3-month period.
KTTA Signals & Forecast
A buy signal was issued from a pivot bottom point on Thursday, June 18, 2026, and so far it has risen 5.22%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Pasithea Therapeutics Corp. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.539 and $0.646. A break-up above any of these levels will issue buy signals. Pasithea Therapeutics Corp. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".
Support, Risk & Stop-loss for Pasithea Therapeutics Corp. stock
Pasithea Therapeutics Corp. finds support from accumulated volume at $0.510 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0673 between high and low, or 13.13%. For the last week, the stock has had daily average volatility of 10.72%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (KTTA) For The Upcoming Trading Day Of Tuesday 30th
For the upcoming trading day on Tuesday, 30th we expect Pasithea Therapeutics Corp. to open at $0.540, and during the day (based on 14 day Average True Range), to move between $0.500 and $0.552, which gives a possible trading interval of +/-$0.0522 (+/-10.45%) up or down from last closing price. If Pasithea Therapeutics Corp. takes out the full calculated possible swing range there will be an estimated 10.45% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $0.539 (2.43%) than the support at $0.510 (3.06%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Pasithea Therapeutics Corp. stock A Buy?
Pasithea Therapeutics Corp. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.
Current score:
-5.080
Strong Sell Candidate
Downgraded
Predicted Fair Opening Price
Predicted fair opening price on June 30, 2026 - $0.540 ( 2.55%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
KTTA Performance
Trading levels for KTTA
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.607 | 15.35% |
| R2 | 0.581 | 10.46% |
| R1 | 0.565 | 7.44% |
| Price | 0.526 | |
| S1 | 0.514 | -2.33% |
| S2 | 0.498 | -5.35% |
| S3 | 0.472 | -10.24% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.645 | 22.60% |
| R2 | 0.560 | 6.44% |
| R1 | 0.539 | 2.43% |
| Price | 0.526 | |
| S1 | 0.510 | -3.06% |
| S2 | 0.502 | -4.52% |
| S3 | 0.500 | -4.96% |
FAQ
Click here for our free guide on how to buy Pasithea Therapeutics Corp. Stock.
Buy KTTA